Literature DB >> 22116667

Activation of AKT is associated with metastasis of nasopharyngeal carcinoma.

Ying Liu1, Long-Hua Chen, Ya-Wei Yuan, Qi-Sheng Li, Ai-Ming Sun, Jian Guan.   

Abstract

Although radiotherapy results of nasopharyngeal carcinoma (NPC) at an early stage are better than other tumors, there is still a portion of patients with NPC who die before 5 years after the treatment; the underlying mechanism remains to be further understood. This study aims to investigate the mechanism by which NPC cells escape from irradiation. Patients with NPC at stage I was included in this study. All the patients were treated with irradiation. NPC biopsies were obtained from each patient before and 1 week after the start of radiotherapy. Expression of AKT in NPC tissue was assessed by Western blotting. NPC cell line, SUNE-1 cells, was treated with irradiation. The levels of AKT in SUNE-1 cells were also assessed. The frequency of apoptotic SUNE-1 cells was evaluated by flow cytometry. The levels of AKT were markedly increased in NPC tissue after treatment with irradiation, which was significantly correlated with NPC metastasis and mortality. After irradiation, NPC cell line, SUNE-1 cells, expressed higher levels of AKT than control cells. The knockdown of AKT in SUNE-1 cells markedly increased apoptotic cell rate. Radiotherapy can increase the levels of AKT in NPC cells that are associated with NPC metastasis and increase in mortality.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22116667     DOI: 10.1007/s13277-011-0272-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  20 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

Review 2.  Update on the management and therapeutic monitoring of advanced nasopharyngeal cancer.

Authors:  Herbert H Loong; Brigette B Ma; Anthony T Chan
Journal:  Hematol Oncol Clin North Am       Date:  2008-12       Impact factor: 3.722

Review 3.  Targeting base excision repair as a sensitization strategy in radiotherapy.

Authors:  Conchita Vens; Adrian C Begg
Journal:  Semin Radiat Oncol       Date:  2010-10       Impact factor: 5.934

Review 4.  New inhibitors of the mammalian target of rapamycin signaling pathway for cancer.

Authors:  Sébastien Albert; Maria Serova; Chantal Dreyer; Marie-Paule Sablin; Sandrine Faivre; Eric Raymond
Journal:  Expert Opin Investig Drugs       Date:  2010-08       Impact factor: 6.206

Review 5.  Protein kinase networks regulating glucocorticoid-induced apoptosis of hematopoietic cancer cells: fundamental aspects and practical considerations.

Authors:  Shlomit Kfir-Erenfeld; Ronit Vogt Sionov; Rachel Spokoini; Orly Cohen; Eitan Yefenof
Journal:  Leuk Lymphoma       Date:  2010-09-20

Review 6.  Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.

Authors:  Vicente E Torres; Alessandra Boletta; Arlene Chapman; Vincent Gattone; York Pei; Qi Qian; Darren P Wallace; Thomas Weimbs; Rudolf P Wüthrich
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

Review 7.  Head and neck carcinomas across the age spectrum: epidemiology, therapy, and late effects.

Authors:  Karen J Marcus; Roy B Tishler
Journal:  Semin Radiat Oncol       Date:  2010-01       Impact factor: 5.934

Review 8.  Nasopharyngeal carcinoma: current management, future directions and dental implications.

Authors:  Mark Agulnik; Joel B Epstein
Journal:  Oral Oncol       Date:  2007-12-03       Impact factor: 5.337

Review 9.  PTEN: new insights into its regulation and function in skin cancer.

Authors:  Mei Ming; Yu-Ying He
Journal:  J Invest Dermatol       Date:  2009-04-02       Impact factor: 8.551

Review 10.  Intensity modulated radiotherapy (IMRT) in the treatment of children and adolescents--a single institution's experience and a review of the literature.

Authors:  Florian Sterzing; Eva M Stoiber; Simeon Nill; Harald Bauer; Peter Huber; Jürgen Debus; Marc W Münter
Journal:  Radiat Oncol       Date:  2009-09-23       Impact factor: 3.481

View more
  17 in total

1.  Improved antitumor effect of ionizing radiation in combination with rapamycin for treating nasopharyngeal carcinoma.

Authors:  Di Wang; Lichen Gao; Xueting Liu; Chuang Yuan; Guihua Wang
Journal:  Oncol Lett       Date:  2017-05-19       Impact factor: 2.967

2.  CIP2A is overexpressed in osteosarcoma and regulates cell proliferation and invasion.

Authors:  Mo Zhai; Lin Cong; Yaxin Han; Guanjun Tu
Journal:  Tumour Biol       Date:  2013-09-08

3.  Decreased ARID1A expression facilitates cell proliferation and inhibits 5-fluorouracil-induced apoptosis in colorectal carcinoma.

Authors:  Chengyao Xie; Lin Fu; Yong Han; Qingchang Li; Enhua Wang
Journal:  Tumour Biol       Date:  2014-05-16

4.  As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial-mesenchymal transition and activation of AKT signaling.

Authors:  Xin-Jian Li; Li-Xia Peng; Jian-Yong Shao; Wen-Hua Lu; Jia-Xing Zhang; Shi Chen; Zhi-Yuan Chen; Yan-Qun Xiang; Ying-Na Bao; Fang-Jing Zheng; Mu-Sheng Zeng; Tie-Bang Kang; Yi-Xin Zeng; Bin Tean Teh; Chao-Nan Qian
Journal:  Carcinogenesis       Date:  2012-05-18       Impact factor: 4.944

5.  Effect of AKT inhibition on epithelial-mesenchymal transition and ZEB1-potentiated radiotherapy in nasopharyngeal carcinoma.

Authors:  Weiguo Chen; Sipei Wu; Gong Zhang; Wenjun Wang; Yongsheng Shi
Journal:  Oncol Lett       Date:  2013-08-29       Impact factor: 2.967

6.  Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.

Authors:  Shih-Hsin Chiu; Chung-Chun Wu; Chih-Yeu Fang; Shu-Ling Yu; Hui-Yu Hsu; Yen-Hung Chow; Jen-Yang Chen
Journal:  Oncotarget       Date:  2014-09-30

7.  Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.

Authors:  Xiao-Min Zhou; Rui Sun; Dong-Hua Luo; Jian Sun; Mei-Yin Zhang; Meng-He Wang; Yang Yang; Hui-Yun Wang; Shi-Juan Mai
Journal:  Oncotarget       Date:  2016-03-22

8.  Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients.

Authors:  Dimitrios Krikelis; Mattheos Bobos; Georgia Karayannopoulou; Liliana Resiga; Sofia Chrysafi; Epaminontas Samantas; Dimitrios Andreopoulos; Vassilios Vassiliou; Elisabeta Ciuleanu; George Fountzilas
Journal:  BMC Clin Pathol       Date:  2013-01-29

9.  Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 has a therapeutic potential and sensitizes cisplatin in nasopharyngeal carcinoma.

Authors:  Fen Yang; Xiao-Jun Qian; Wei Qin; Rong Deng; Xiao-Qi Wu; Juan Qin; Gong-Kan Feng; Xiao-Feng Zhu
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

10.  Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal cancer cells.

Authors:  Ke-Feng Wang; Hang Yang; Wen-Qi Jiang; Su Li; Yu-Chen Cai
Journal:  Int J Mol Med       Date:  2015-10-16       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.